Clinical Trial Update: Effect of Administration of 3rd Generation Cephalosporin on the Digestive Carrying of 3rd Generation Cephalosporin-resistant Enterobacteriaceae (CEF-IMPACT) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of a 3rd generation cephalosporin on the digestive carriage of cephalosporin-resistant Enterobacteriaceae.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Disease Due to Resistant Enterobacteriaceae

Drugs mentioned

• 3rd generation cephalosporin

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Infectious Disease - Resistant Enterobacteriaceae (Diagnosis) | Phase 4 | Status: UNKNOWN